Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 405M
16.67x0.46x10x2.55% 133B
13.47x1.74x8.58x0.76% 90.2B
12.72x1.45x8.79x2.67% 27.41B
21.58x2.35x11.87x1.57% 22.96B
29.06x5.35x22.59x2.4% 19.9B
8.11x1.27x5.99x-.--% 17.59B
16.04x1.5x7.67x4.37% 15.5B
15.92x1.83x8.78x0.72% 14.95B
13.91x1.03x5.79x3.29% 12.75B
Average 16.39x 1.89x 10.01x 2.04% 35.46B
Weighted average by Cap. 15.98x 1.42x 9.87x 1.94%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.